Resources
-
WCBP 2023 Summary Infographic
Summary Infographic: WCBP 2023
-
CMC Strategy Forum North America 2023 Summary Infographic
Summary Infographic: CMC Strategy Forum North America 2023
-
CMC Strategy Forum Japan 2022 Summary Infographic
Summary Infographic: CMC Strategy Forum Japan 2022
-
On Application of Multi-Scale Modelling for Facility Simulation and Process Control Strategy
Speaker Presentation Babi Deenesh Novo Nordisk 2020
-
The Path to Success for mRNA Vaccines
Speaker Presentation Ulmer Jeffrey TechImmune LLC_Immorna Therapeutics 2022
-
Capping, Poly(A) tail and LNP Analysis for mRNA Vaccine Product Development
Speaker Presentation Zeng Qi GlaxoSmithKline 2022
-
Ensuring Quality and Safety of mRNA Vaccines Today & Tomorrow
Speaker Presentation Acharya Sarita USP 2022
-
CMC Strategy Forum Japan 2022 Scientific Program
Scientific Program: CMC Strategy Forum Japan 2022
-
Targeted Revision of ICH Q1s/Q5C - Opportunities with Science and Risk-Based Approaches
Speaker Presentation Zimmerman Boris Genentech, a Member of the Roche Group 2022
-
Industry Perspective on Polysorbate Degradation & Control Strategies for Biopharmaceutical Products - A View of EFPIA Working Group
Speaker Presentation Wuchner Klaus and Bechtold Peters Karoline Janssen 2022
-
Viral Safety - Panel Discussion Questions 2022
Viral Safety - Panel Discussion Questions 2022
-
Differences in Regulations on Gene Modified Organisms Between japan, Europe, and the United States
Speaker Presentation Tajima Gentaro Pfizer R&D Japan G.K. 2022
-
Concept of the ICH-Q5A Second Revision
Speaker Presentation Sakurai Akira PMDA 2022
-
Proteinaceous Visible Particle in Liquid Monoclonal Antibody Formulations
Speaker Presentation Saitoh Satoshi Chugai 2022
-
Composition of the Application Material on Quality for the MAA of Regenerative Medical Products
Speaker Presentation Nishikawa Atsushi PMDA 2022
-
Global Regulatory Considerations for
Allogeneic Cell Therapies
Speaker Presentation Momonoi Yoko Takeda Pharmaceuticals 2022
-
China's Regulatory Framework for Biological
Products and the Latest Trend
Speaker Presentation Li Min Center for Drug Evaluation (CDE) 2022
-
Regulatory Considerations for Moving from Emergency Use Authorization to Biological License Application for U.S. Products
Speaker Presentation Levis Robin CBER FDA 2022
-
Using Stability Prior Knowledge From ‘Like-molecules’ to Determine Shelf-life
Speaker Presentation Lennard Andrew Amgen 2022
-
An Industry Perspective on CHO Cell Product Virus Safety
Speaker Presentation Kobayashi Shohei Chugai 2022